1 Hereceptin Biosimilar Market Overview
1.1 Hereceptin Biosimilar Product Scope
1.2 Hereceptin Biosimilar Segment by Type
1.2.1 Global Hereceptin Biosimilar Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Capsule
1.3 Hereceptin Biosimilar Segment by Application
1.3.1 Global Hereceptin Biosimilar Sales Comparison by Application (2020-2026)
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.3.4 Others
1.4 Hereceptin Biosimilar Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hereceptin Biosimilar Sales Growth Rate (2015-2026)
1.4.2 Global Hereceptin Biosimilar Revenue and Growth Rate (2015-2026)
1.4.3 Global Hereceptin Biosimilar Price Trends (2015-2026)
2 Hereceptin Biosimilar Estimate and Forecast by Region
2.1 Global Hereceptin Biosimilar Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hereceptin Biosimilar Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hereceptin Biosimilar Sales Market Share by Region (2015-2020)
2.2.2 Global Hereceptin Biosimilar Revenue Market Share by Region (2015-2020)
2.3 Global Hereceptin Biosimilar Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hereceptin Biosimilar Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hereceptin Biosimilar Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.2 Europe Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.3 China Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.4 Japan Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hereceptin Biosimilar Estimates and Projections (2015-2026)
2.4.6 India Hereceptin Biosimilar Estimates and Projections (2015-2026)
3 Global Hereceptin Biosimilar Competition Landscape by Players
3.1 Global Top Hereceptin Biosimilar Players by Sales (2015-2020)
3.2 Global Top Hereceptin Biosimilar Players by Revenue (2015-2020)
3.3 Global Hereceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereceptin Biosimilar as of 2019)
3.4 Global Hereceptin Biosimilar Average Price by Company (2015-2020)
3.5 Manufacturers Hereceptin Biosimilar Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hereceptin Biosimilar Players (Opinion Leaders)
4 Global Hereceptin Biosimilar Market Size by Type
4.1 Global Hereceptin Biosimilar Historic Market Review by Type (2015-2020)
4.1.1 Global Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
4.1.2 Global Hereceptin Biosimilar Revenue Market Share by Type (2015-2020)
4.1.3 Global Hereceptin Biosimilar Price by Type (2015-2020)
4.2 Global Hereceptin Biosimilar Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hereceptin Biosimilar Sales Forecast by Type (2021-2026)
4.2.2 Global Hereceptin Biosimilar Revenue Forecast by Type (2021-2026)
4.2.3 Global Hereceptin Biosimilar Price Forecast by Type (2021-2026)
5 Global Hereceptin Biosimilar Market Size by Application
5.1 Global Hereceptin Biosimilar Historic Market Review by Application (2015-2020)
5.1.1 Global Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
5.1.2 Global Hereceptin Biosimilar Revenue Market Share by Application (2015-2020)
5.1.3 Global Hereceptin Biosimilar Price by Application (2015-2020)
5.2 Global Hereceptin Biosimilar Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hereceptin Biosimilar Sales Forecast by Application (2021-2026)
5.2.2 Global Hereceptin Biosimilar Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereceptin Biosimilar Price Forecast by Application (2021-2026)
6 United States Hereceptin Biosimilar Market Facts & Figures
6.1 United States Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
6.2 United States Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
6.3 United States Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
7 Europe Hereceptin Biosimilar Market Facts & Figures
7.1 Europe Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
7.2 Europe Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
7.3 Europe Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
8 China Hereceptin Biosimilar Market Facts & Figures
8.1 China Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
8.2 China Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
8.3 China Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
9 Japan Hereceptin Biosimilar Market Facts & Figures
9.1 Japan Hereceptin Biosimilar Sales Market Share by Company (3015-3030)
9.2 Japan Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
9.3 Japan Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
10 Southeast Asia Hereceptin Biosimilar Market Facts & Figures
10.1 Southeast Asia Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
11 India Hereceptin Biosimilar Market Facts & Figures
11.1 India Hereceptin Biosimilar Sales Market Share by Company (2015-2020)
11.2 India Hereceptin Biosimilar Sales Market Share by Type (2015-2020)
11.3 India Hereceptin Biosimilar Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Hereceptin Biosimilar Business
12.1 Mylan N.V.
12.1.1 Mylan N.V. Corporation Information
12.1.2 Mylan N.V. Business Overview
12.1.3 Mylan N.V. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Mylan N.V. Hereceptin Biosimilar Products Offered
12.1.5 Mylan N.V. Recent Development
12.2 AryoGen Biopharma
12.2.1 AryoGen Biopharma Corporation Information
12.2.2 AryoGen Biopharma Business Overview
12.2.3 AryoGen Biopharma Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AryoGen Biopharma Hereceptin Biosimilar Products Offered
12.2.5 AryoGen Biopharma Recent Development
12.3 Genor Biopharma
12.3.1 Genor Biopharma Corporation Information
12.3.2 Genor Biopharma Business Overview
12.3.3 Genor Biopharma Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Genor Biopharma Hereceptin Biosimilar Products Offered
12.3.5 Genor Biopharma Recent Development
12.4 Celltrion Inc.
12.4.1 Celltrion Inc. Corporation Information
12.4.2 Celltrion Inc. Business Overview
12.4.3 Celltrion Inc. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celltrion Inc. Hereceptin Biosimilar Products Offered
12.4.5 Celltrion Inc. Recent Development
12.5 Amgen Inc.
12.5.1 Amgen Inc. Corporation Information
12.5.2 Amgen Inc. Business Overview
12.5.3 Amgen Inc. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Amgen Inc. Hereceptin Biosimilar Products Offered
12.5.5 Amgen Inc. Recent Development
12.6 Mabion S.A.
12.6.1 Mabion S.A. Corporation Information
12.6.2 Mabion S.A. Business Overview
12.6.3 Mabion S.A. Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mabion S.A. Hereceptin Biosimilar Products Offered
12.6.5 Mabion S.A. Recent Development
12.7 The Instituto Vital Brazil
12.7.1 The Instituto Vital Brazil Corporation Information
12.7.2 The Instituto Vital Brazil Business Overview
12.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.7.4 The Instituto Vital Brazil Hereceptin Biosimilar Products Offered
12.7.5 The Instituto Vital Brazil Recent Development
12.8 F. Hoffmann-La Roche AG
12.8.1 F. Hoffmann-La Roche AG Corporation Information
12.8.2 F. Hoffmann-La Roche AG Business Overview
12.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.8.4 F. Hoffmann-La Roche AG Hereceptin Biosimilar Products Offered
12.8.5 F. Hoffmann-La Roche AG Recent Development
12.9 Biocon
12.9.1 Biocon Corporation Information
12.9.2 Biocon Business Overview
12.9.3 Biocon Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Biocon Hereceptin Biosimilar Products Offered
12.9.5 Biocon Recent Development
12.10 Gedeon Richter Plc
12.10.1 Gedeon Richter Plc Corporation Information
12.10.2 Gedeon Richter Plc Business Overview
12.10.3 Gedeon Richter Plc Hereceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Gedeon Richter Plc Hereceptin Biosimilar Products Offered
12.10.5 Gedeon Richter Plc Recent Development
13 Hereceptin Biosimilar Manufacturing Cost Analysis
13.1 Hereceptin Biosimilar Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereceptin Biosimilar
13.4 Hereceptin Biosimilar Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereceptin Biosimilar Distributors List
14.3 Hereceptin Biosimilar Customers
15 Market Dynamics
15.1 Hereceptin Biosimilar Market Trends
15.2 Hereceptin Biosimilar Opportunities and Drivers
15.3 Hereceptin Biosimilar Market Challenges
15.4 Hereceptin Biosimilar Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
【掲載企業】
Mylan N.V.、AryoGen Biopharma、Genor Biopharma、Celltrion Inc.、Amgen Inc.、Mabion S.A.、The Instituto Vital Brazil、F. Hoffmann-La Roche AG、Biocon、Gedeon Richter Plc
【免責事項】
https://www.globalresearch.jp/disclaimer